NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,268,421 | +79.7% | 37,719 | +126.9% | 0.09% | +91.8% |
| Q3 2022 | $1,262,000 | -66.9% | 16,622 | -63.9% | 0.05% | -70.1% |
| Q1 2022 | $3,811,000 | +456.4% | 46,000 | +404.2% | 0.16% | +281.4% |
| Q4 2021 | $685,000 | -78.2% | 9,124 | -66.2% | 0.04% | -81.1% |
| Q3 2021 | $3,137,000 | +151.6% | 27,000 | +186.1% | 0.23% | +95.7% |
| Q1 2021 | $1,247,000 | +37.0% | 9,436 | +79.4% | 0.12% | -25.2% |
| Q4 2020 | $910,000 | +135.8% | 5,260 | +51.5% | 0.16% | +98.7% |
| Q3 2020 | $386,000 | – | 3,472 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |